Increasing intake of antioxidant-rich cherries may help lower the risk of metabolic syndrome and cardiovascular disease, according to new study data presented at the Experimental Biology annual meeting, held in Washington DC.
In the study, whole tart cherry powder was fed to two groups of rats as either 1% or 10% of their diet for 90 days. Other rats received diets with no cherry powder, but with an equal amount of carbohydrates and calories to those that received cherry powder. Results showed that the cherry-enriched diets significantly lowered total cholesterol levels, triglycerides, insulin and fasting glucose levels after 90 days. All of these measures are factors that are linked to metabolic syndrome.
The USA-based Michigan University study also showed the cherry-fed groups had lower levels of a plasma marker of oxidative damage and increased blood antioxidant capacity. Additionally, the cherry-enriched diets reduced the accumulation of triglycerides and cholesterol in the liver. The amount of cherries used is estimated to be up to one and a half cups of whole frozen cherries or a little more than half a cup of dried cherries.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze